BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 16, 2013
View Archived Issues
Eisai presents highlights of first quarter of fiscal 2013
Read More
Otsuka updates accomplishments of second quarter 2013
Read More
Novel biomarker is associated with response to anti-EGFR cancer treatment
Read More
Preclinical characterization of a GIP analogue for the treatment of diabetes
Read More
Celgene presents phase III results for nab-paclitaxel in metastatic melanoma
Read More
Grafix shows efficacy in stem cell study for diabetic foot ulcers
Read More
Reliable insulin delivery seen with Adagio inhalable insulin in phase I/II trial
Read More
A novel COX-2 inhibitor shows potential as adjuvant radiosensitizer in melanoma cell lines
Read More
Lilly's phase III trial of necitumumab in NSCLC meets primary endpoint of overall survival
Read More
Atlantic Pharmaceuticals completes pre-IND meeting with FDA for abuse-deterrent hydrocodone
Read More
Patrys discloses additional data from phase I/II trial of PAT-SM6 in MM
Read More
Trial of CPX-351 in high-risk leukemia and myelodysplastic syndrome initiated
Read More
Myelin Repair Foundation and Gencia Corporation to collaborate on multiple sclerosis therapeutics
Read More
AdvanDx launches Gram-Negative QuickFISH BC assay
Read More
GW Pharmaceuticals opens U.S. IND application for phase III Sativex program
Read More
Taisho Pharmaceutical presents new mGlu2 receptor antagonists
Read More
Sanford-Burnham and Pfizer to identify targets for treatment of diabetes
Read More
Japanese researchers patent novel agents for promoting osteogenesis
Read More
FDA approves liquid form of enalapril
Read More
Eli Lilly discloses new MGAT2 inhibitors for hypertriglyceridemia
Read More
Acasti Pharma reports data from phase II CaPre trial
Read More
Suda acquires NovaDel Pharma assets
Read More
Altor receives IND clearance to advance ALT-803 into clinical trials in melanoma
Read More
Mallinckrodt submits results from PK study requested by FDA in response to Pennsaid 2% NDA
Read More
ALN-AT3 receives orphan drug designation from the FDA
Read More
Boehringer Ingelheim enters agreement to study real-world use of oral anticoagulants
Read More
Dosing begins in phase I study of DX-2930
Read More
Cedars-Sinai begins phase I trial of Copaxone as immunization for Alzheimer's disease
Read More
